Federated Hermes’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-2,574
| Closed | -$131K | – | 2195 |
|
2022
Q4 | $131K | Buy |
+2,574
| New | +$131K | ﹤0.01% | 1611 |
|
2022
Q3 | – | Sell |
-329
| Closed | -$22K | – | 2191 |
|
2022
Q2 | $22K | Buy |
+329
| New | +$22K | ﹤0.01% | 1756 |
|
2020
Q2 | – | Sell |
-1,721
| Closed | -$496K | – | 2307 |
|
2020
Q1 | $496K | Sell |
1,721
-52,763
| -97% | -$15.2M | ﹤0.01% | 1380 |
|
2019
Q4 | $15.7M | Buy |
+54,484
| New | +$15.7M | 0.03% | 480 |
|
2019
Q2 | – | Sell |
-6,119
| Closed | -$536K | – | 2190 |
|
2019
Q1 | $536K | Sell |
6,119
-13,441
| -69% | -$1.18M | ﹤0.01% | 1428 |
|
2018
Q4 | $2.75M | Sell |
19,560
-164
| -0.8% | -$23K | 0.01% | 926 |
|
2018
Q3 | $5.04M | Buy |
19,724
+19,561
| +12,001% | +$5M | 0.01% | 801 |
|
2018
Q2 | $42K | Buy |
163
+149
| +1,064% | +$38.4K | ﹤0.01% | 1710 |
|
2018
Q1 | $3K | Buy |
+14
| New | +$3K | ﹤0.01% | 2028 |
|